Profit Or Loss [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166138

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
2,087 EUR
900,000 EUR
Profit (loss) from operating activities
15,993 EUR
11,638 EUR
Finance income
898,000 EUR
466,000 EUR
Finance costs
285,000 EUR
730,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
147,000 EUR
130,000 EUR
Profit (loss) before tax
15,380 EUR
11,901 EUR
Tax expense (income)
- EUR
4,000 EUR
Profit (loss)
15,380 EUR
11,906 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
15,380 EUR
11,906 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
55.00
43.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.